Cholinergic and endocannabinoid neuromodulatory effects overlap on neurons of the pedunculopontine nucleus of mice

NeuroReport

Volumn 26, Issue 5, 2015, Pages 273-278

  Kovács, Adrienn ^a   Bordás, Csilla ^a   Pál, Balázs ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Arachidonyl 2 chloroethylamide; Carbachol; CB1 receptor; Muscarinic; Reticular activating system

Indexed keywords

ARACHIDONYL 2' CHLOROETHYLAMIDE; CANNABINOID 1 RECEPTOR AGONIST; CARBACHOL; UNCLASSIFIED DRUG; ARACHIDONIC ACID DERIVATIVE; ARACHIDONYL-2-CHLOROETHYLAMIDE; CB10 PROTEIN, BOS TAURUS; CHOLINERGIC RECEPTOR STIMULATING AGENT; COLLAGEN; PEPTIDE FRAGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; BRAIN SLICE; CELL MEMBRANE DEPOLARIZATION; CHOLINERGIC STIMULATION; CONTROLLED STUDY; HYPERPOLARIZATION; MESENCEPHALON; MOUSE; NERVE CELL MEMBRANE POTENTIAL; NERVE CELL MEMBRANE STEADY POTENTIAL; NEUROMODULATION; NONHUMAN; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PRIORITY JOURNAL; SUBSTANTIA NIGRA PARS COMPACTA; SUPERIOR CEREBELLAR PEDUNCLE; WHOLE CELL PATCH CLAMP; AGONISTS; ANIMAL; DRUG EFFECTS; MEMBRANE POTENTIAL; NERVE CELL; PHYSIOLOGY;

ANIMALS; ARACHIDONIC ACIDS; CARBACHOL; CHOLINERGIC AGONISTS; COLLAGEN; MEMBRANE POTENTIALS; MICE; NEURONS; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PEPTIDE FRAGMENTS;

EID: 84924965485     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0000000000000342     Document Type: Article

References (20)

1. Garcia-Rill E, Simon C, Smith K, Kezunovic N, Hyde J. The pedunculopontine tegmental nucleus: from basic neuroscience to neurosurgical applications: arousal from slices to humans: implications for DBS. J Neural Transm 2011; 118:1397-1407.
2. Winn P. How best to consider the structure and function of the pedunculopontine tegmental nucleus: evidence from animal studies. J Neurol Sci 2006; 248 (1-2):234-250.
3. José Lanc¸a A, Sanelli TR, Corrigall WA. Nicotine-induced fos expression in the pedunculopontine mesencephalic tegmentum in the rat. Neuropharmacology 2000; 39:2808-2817.
4. Ye M, Hayar A, Strotman B, Garcia-Rill E. Cholinergic modulation of fast inhibitory and excitatory transmission to pedunculopontine thalamic projecting neurons. J Neurophysiol 2010; 103:2417-2432.
5. Kezunovic N, Hyde J, Goitia B, Bisagno V, Urbano FJ, Garcia-Rill E. Muscarinic modulation of high frequency oscillations in pedunculopontine neurons. Front Neurol 2013; 4:176.
6. Leonard CS, Llinás R. Serotonergic and cholinergic inhibition of mesopontine cholinergic neurons controlling REM sleep: an in vitro electrophysiological study. Neuroscience 1994; 59:309-330.
7. Grace KP, Liu H, Horner RL. 5-HT1A receptor-responsive pedunculopontine tegmental neurons suppress REM sleep and respiratory motor activity. J Neurosci 2012; 32:1622-1633.
8. Bay K, Mamiya K, Good C, Skinner RD, Garcia-Rill E. Alpha-2 adrenergic regulation of pedunculopontine nucleus (PPN) neurons during development. Neuroscience 2006; 141:769-779.
9. Kim J, Nakajima K, Oomura Y, Wayner MJ, Sasaki K. Orexin-A and ghrelin depolarize the same pedunculopontine tegmental neurons in rats: an in vitro study. Peptides 2009; 30:1328-1335.
10. Murillo-Rodriguez E. The role of the CB1 receptor in the regulation of sleep. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32:1420-1427.
11. Ko{combining double acute accent}szeghy Á, Kovács A, Bíró T, Szücs P, Vincze J, Hegyi Z, et al. Endocannabinoid signaling modulates neurons of the pedunculopontine nucleus (PPN) via astrocytes. Brain Struct Funct 2014. [Epub ahead of print].
12. Mena-Segovia J, Sims HM, Magill PJ, Bolam JP. Cholinergic brainstem neurons modulate cortical gamma activity during slow oscillations. J Physiol 2008; 586:2947-2960.
13. Datta S, Siwek DF. Single cell activity patterns of pedunculopontine tegmentum neurons across the sleep-wake cycle in the freely moving rats. J Neurosci Res 2002; 70:611-621.
14. Garcia-Rill E, Charlesworth A, Heister D, Ye M, Hayar A. The developmental decrease in REM sleep: the role of transmitters and electrical coupling. Sleep 2008; 31:673-690.
15. Thakkar MM, Strecker RE, McCarley RW. Behavioral state control through differential serotonergic inhibition in the mesopontine cholinergic nuclei: a simultaneous unit recording and microdialysis study. J Neurosci 1998; 18:5490-5497.
16. Ros H, Magill PJ, Moss J, Bolam JP, Mena-Segovia J. Distinct types of noncholinergic pedunculopontine neurons are differentially modulated during global brain states. Neuroscience 2010; 170:78-91.
17. Boucetta S, Cissé Y, Mainville L, Morales M, Jones BE. Discharge profiles across the sleep-waking cycle of identified cholinergic, GABAergic, and glutamatergic neurons in the pontomesencephalic tegmentum of the rat. J Neurosci 2014; 34:4708-4727.
18. Demuth DG, Molleman A. Cannabinoid signalling. Life Sci 2006; 78:549-563.
19. Romano MR, Lograno MD. Signaling cross-talk between cannabinoid and muscarinic systems actives Rho-kinase and increases the contractile responses of the bovine ciliary muscle. Eur J Pharmacol 2013; 702 (1-3):174-179.
20. Rinaldo L, Hansel C. Muscarinic acetylcholine receptor activation blocks long-term potentiation at cerebellar parallel fiber-Purkinje cell synapses via cannabinoid signaling. Proc Natl Acad Sci USA 2013; 110:11181-11186.